© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Diebold Nixdorf, Incorporated (DBD) shows an Average True Range (ATR) of 1.62 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 191.84K, indicating liquidity. These fundamental metrics provide insight into DBD's underlying financial health and market activity.
Diebold Nixdorf, Incorporated (DBD) technical indicators as of January 1, 2026: the SMA 20 is 0.82%, SMA 50 at 6.19%, and SMA 200 at 21.96%. The RSI 14 value is 57.8, suggesting its current momentum. These technical analysis signals help assess DBD's price trends and potential future movements.
Diebold Nixdorf, Incorporated (DBD) stock performance overview as of January 1, 2026: The 52-week high is $69.94 (currently -2.93% below), and the 52-week low is $34.88 (currently 94.67% above). Over the past year, DBD's performance is 55.68%, compared to the S&P 500's 12.29% change.
According to market data, Diebold Nixdorf, Incorporated (DBD) stock's recent performance metrics show that over the last month, DBD is 5.22%, with a Year-to-Date (YTD) performance of 57.74%. Over the past year, the stock has seen a 55.68% change. These figures summarize DBD's price movements across various periods, reflecting its historical returns.
According to current financial data, DBD stock's P/E (TTM) ratio is 49.29, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -0.43. Key valuation ratios for DBD, including P/S (0.69), P/B (2.28), and P/FCF (10.26), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.